Zinc Coordination by Thymosin β4: Structural Determinants and Functional Implications.
This study investigated, for the first time, how the small peptide Thymosin β4 (Tβ4) interacts with zinc ions (Zn²⁺) at physiological pH. Using a panel of biophysical techniques — including zeta potential analysis, dynamic light scattering (DLS), electrospray ionization mass spectrometry (ESI-MS), nuclear magnetic resonance (NMR) spectroscopy, and scanning electron microscopy with elemental mapping (SEM/EDS) — the researchers characterized the structural and chemical consequences of Zn²⁺ binding to this intrinsically disordered 43-amino-acid peptide. The study found that Zn²⁺ progressively neutralizes Tβ4's negative surface charge, triggering a sharp aggregation transition. ESI-MS identified peptide-to-zinc complexes at a 1:3 molar ratio, while DLS and SEM confirmed formation of compact, low-solubility supramolecular assemblies. NMR data indicated that Zn²⁺ binding does not induce folding of the peptide. Importantly, the study compared the experimentally determined critical aggregation concentration with known physiological extracellular Zn²⁺ levels, concluding that aggregation is unlikely under normal plasma or interstitial conditions but could occur in Zn-rich microenvironments such as the synaptic cleft. The authors propose that Zn²⁺-mediated Tβ4 assembly may be relevant in neurological or inflammatory contexts. This is a foundational biochemical characterization study with no direct in vivo or clinical component.
Why this grade: All experiments were conducted entirely in vitro using biophysical and analytical chemistry techniques on isolated peptide and metal ions, with no animal models or human subjects involved.
Thymosin β4 (Tβ4) is a highly acidic, intrinsically disordered 43-amino-acid peptide with diverse biological functions, yet its interactions with metal ions remain poorly understood. In this study, we provide the first experimental demonstration that Tβ4 forms discrete Zn 2+ -bound adducts and undergoes Zn 2+ -induced aggregation under physiological pH conditions. Combining zeta potential analysis, dynamic light scattering (DLS), electrospray ionization mass spectrometry (ESI-MS), nuclear magnetic resonance (NMR) spectroscopy, and scanning electron microscopy with elemental mapping (SEM/EDS), we show that Zn(II) binding progressively neutralizes Tβ4's negative surface charge and triggers a sharp aggregation transition. ESI-MS unambiguously identifies Tβ4/Zn(II) complexes of peptide-to-zinc molar ratio 1:3, while DLS and SEM reveal the formation of compact, low-solubility supramolecular assemblies. NMR measurements support a metal-induced aggregation, confirming the absence of folding upon Zn(II) binding. By quantitatively comparing the experimentally determined critical aggregation concentration with physiologically observed extracellular Zn(II) ranges, we demonstrate that aggregation is unlikely in plasma or basal interstitial environments but may become feasible in Zn-rich microdomains, such as the synaptic cleft, where transient Zn(II) levels can exceed 1 μM. These findings introduce a previously unrecognized dimension of Tβ4 chemistry and suggest that a Zn(II)-mediated supramolecular assembly of Tβ4 could influence peptide behavior in neurological or inflammatory conditions characterized by elevated extracellular Zn(II). This work establishes a foundational biochemical framework for future studies aimed at elucidating the biological implications of Tβ4/Zn(II) complexation and aggregation in vivo.
Educational summary of published research — not medical advice. Full text is shown only where licensing permits.